Single‐cell and spatial analyses reveal the association between gene expression of glutamine synthetase with the immunosuppressive phenotype of APOE+CTSZ+TAM in cancers

An immunosuppressive state is regulated by various factors in the tumor microenvironment (TME), including, but not limited to, metabolic plasticity of immunosuppressive cells and cytokines secreted by these cells. We used single‐cell RNA‐sequencing (scRNA‐seq) data and applied single‐cell flux estimation analysis to characterize the link between metabolism and cellular function within the hypoxic TME of colorectal (CRC) and lung cancer. In terms of metabolic heterogeneity, we found myeloid cells potentially inclined to accumulate glutamine but tumor cells inclined to accumulate glutamate. In particular, we uncovered a tumor‐associated macrophage (TAM) subpopulation, APOE+CTSZ+TAM, that was present in high proportions in tumor samples and exhibited immunosuppressive characteristics through upregulating the expression of anti‐inflammatory genes. The proportion of APOE+CTSZ+TAM and regulatory T cells (Treg) were positively correlated across CRC scRNA‐seq samples. APOE+CTSZ+TAM potentially interacted with Treg via CXCL16–CCR6 signals, as seen by ligand–receptor interactions analysis. Notably, glutamate‐to‐glutamine metabolic flux score and glutamine synthetase (GLUL) expression were uniquely higher in APOE+CTSZ+TAM, compared with other cell types within the TME. GLUL expression in macrophages was positively correlated with anti‐inflammatory score and was higher in high‐grade and invasive tumor samples. Moreover, spatial transcriptome and multiplex immunofluorescence staining of samples showed that APOE+CTSZ+TAM and Treg potentially colocalized in the tissue sections from CRC clinical samples. These results highlight the specific role and metabolic characteristic of the APOE+CTSZ+TAM subpopulation and provide a new perspective for macrophage subcluster‐targeted therapeutic interventions or metabolic checkpoint‐based cancer therapies.

[1]  Simiao Zhang,et al.  Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer , 2022, Cell death & disease.

[2]  Huanming Yang,et al.  Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays , 2021, Cell.

[3]  Fabian J Theis,et al.  Toward modeling metabolic state from single-cell transcriptomics , 2021, Molecular metabolism.

[4]  Xudong Wu,et al.  ALKBH5 Facilitates Hypoxia-Induced Paraspeckle Assembly and IL8 Secretion to Generate an Immunosuppressive Tumor Microenvironment , 2021, Cancer Research.

[5]  Linda T. Nieman,et al.  Spatially organized multicellular immune hubs in human colorectal cancer , 2021, Cell.

[6]  Qin Ma,et al.  A graph neural network model to estimate cell-wise metabolic flux using single-cell RNA-seq data , 2021, Genome research.

[7]  A. De Grassi,et al.  N‐acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages , 2021, EMBO reports.

[8]  H. Crawford,et al.  Myeloid Cell Mediated Ilmmune Suppression in Pancreatic Cancer , 2021, Cellular and molecular gastroenterology and hepatology.

[9]  Ariel J. Levine,et al.  Confronting false discoveries in single-cell differential expression , 2021, Nature Communications.

[10]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity , 2021, Nature Reviews Immunology.

[11]  E. Ruppin,et al.  Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma , 2020, Nature Communications.

[12]  Y. Saeys,et al.  Macrophages are metabolically heterogeneous within the tumor microenvironment. , 2020, Cell reports.

[13]  M. Mazzone,et al.  Glufosinate constrains synchronous and metachronous metastasis by promoting anti‐tumor macrophages , 2020, EMBO molecular medicine.

[14]  Yutaka Suzuki,et al.  Single-cell sequencing techniques from individual to multiomics analyses , 2020, Experimental & Molecular Medicine.

[15]  Ping-Chih Ho,et al.  Lactate modulation of immune responses in inflammatory versus tumour microenvironments , 2020, Nature Reviews Immunology.

[16]  Hongli Du,et al.  Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data , 2020, Cancers.

[17]  A. Chinnaiyan,et al.  Cancer SLC43A2 alters T cell methionine metabolism and histone methylation , 2020, Nature.

[18]  Jung-Il Lee,et al.  Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma , 2020, Nature Communications.

[19]  D. Lambrechts,et al.  A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling , 2020, Cell Research.

[20]  M. Efremova,et al.  CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes , 2020, Nature Protocols.

[21]  M. Bar‐eli,et al.  MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma , 2020, Oncoimmunology.

[22]  Sun Wook Cho,et al.  CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer , 2019, Scientific Reports.

[23]  J. Kos,et al.  Cysteine Cathepsins in Tumor-Associated Immune Cells , 2019, Front. Immunol..

[24]  Zemin Zhang,et al.  GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..

[25]  G. Mills,et al.  Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy , 2019, Nature Metabolism.

[26]  H. Nishikawa,et al.  Regulatory T cells in cancer immunosuppression — implications for anticancer therapy , 2019, Nature Reviews Clinical Oncology.

[27]  Lydia Y. Liu,et al.  Molecular landmarks of tumor hypoxia across cancer types , 2019, Nature Genetics.

[28]  Fan Zhang,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.

[29]  J. Pollard,et al.  Targeting macrophages: therapeutic approaches in cancer , 2018, Nature Reviews Drug Discovery.

[30]  Wei Li,et al.  Tumor-associated macrophages promote the metastasis of ovarian carcinoma cells by enhancing CXCL16/CXCR6 expression. , 2018, Pathology, research and practice.

[31]  Ambrose J. Carr,et al.  Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment , 2018, Cell.

[32]  Aviv Regev,et al.  Induction and transcriptional regulation of the co-inhibitory gene module in T cells , 2018, Nature.

[33]  Fabian J Theis,et al.  SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.

[34]  A. Guarini,et al.  Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M 1-like Phenotype and Inhibits Tumor Metastasis Graphical , 2018 .

[35]  C. Ries,et al.  Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy , 2017, Journal of Immunotherapy for Cancer.

[36]  Chih-Hung Chou,et al.  α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming , 2017, Nature Immunology.

[37]  C. Dang,et al.  From Krebs to clinic: glutamine metabolism to cancer therapy , 2016, Nature Reviews Cancer.

[38]  Christian Frezza,et al.  Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival , 2016, Nature Communications.

[39]  C. Weston,et al.  The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer , 2014, British Journal of Cancer.

[40]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[41]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[42]  J. Kos,et al.  Cysteine cathepsins: regulators of antitumour immune response , 2006, Expert opinion on biological therapy.